NZ596058A - Influenza hemagglutinin compositions and uses thereof - Google Patents
Influenza hemagglutinin compositions and uses thereofInfo
- Publication number
- NZ596058A NZ596058A NZ596058A NZ59605810A NZ596058A NZ 596058 A NZ596058 A NZ 596058A NZ 596058 A NZ596058 A NZ 596058A NZ 59605810 A NZ59605810 A NZ 59605810A NZ 596058 A NZ596058 A NZ 596058A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ectodomain
- hemagglutinin protein
- fragment
- influenza virus
- virus hemagglutinin
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title abstract 7
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title abstract 7
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title abstract 7
- 101710176177 Protein A56 Proteins 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000185 hemagglutinin Substances 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 6
- 239000012634 fragment Substances 0.000 abstract 5
- 239000002245 particle Substances 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159262 | 2009-04-30 | ||
| PCT/EP2010/055944 WO2010125202A1 (en) | 2009-04-30 | 2010-04-30 | Influenza hemagglutinin compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ596058A true NZ596058A (en) | 2013-08-30 |
Family
ID=42790940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ596058A NZ596058A (en) | 2009-04-30 | 2010-04-30 | Influenza hemagglutinin compositions and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120263743A1 (enExample) |
| EP (1) | EP2424570A1 (enExample) |
| JP (1) | JP2012525134A (enExample) |
| CN (1) | CN102573915B (enExample) |
| AU (1) | AU2010243490A1 (enExample) |
| CA (1) | CA2759873A1 (enExample) |
| NZ (1) | NZ596058A (enExample) |
| SG (1) | SG175382A1 (enExample) |
| WO (1) | WO2010125202A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106822887A (zh) * | 2017-01-26 | 2017-06-13 | 中国科学院微生物研究所 | 一种流感病毒四价亚单位疫苗及其应用 |
| MA55313A (fr) * | 2019-03-13 | 2022-01-19 | Generation Bio Co | Vecteurs d'adn non viraux et leurs utilisations pour exprimer des agents thérapeutiques du facteur viii |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU781396B2 (en) * | 1999-07-20 | 2005-05-19 | Morphosys Ag | Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| US7320793B2 (en) * | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
| EP2196217A1 (en) * | 2001-09-14 | 2010-06-16 | Cytos Biotechnology AG | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| CN100509057C (zh) * | 2001-11-07 | 2009-07-08 | 赛托斯生物技术公司 | 用于治疗骨病的抗原阵列 |
| RU2324704C2 (ru) * | 2002-07-17 | 2008-05-20 | Цитос Байотекнолоджи Аг | Молекулярные массивы антигенов |
| KR20060031607A (ko) * | 2003-07-10 | 2006-04-12 | 사이토스 바이오테크놀로지 아게 | 패킹된 바이러스-양 입자 |
| CN101023103A (zh) * | 2004-09-21 | 2007-08-22 | 赛托斯生物技术公司 | 包含ap205外壳蛋白和抗原性多肽的融合蛋白的病毒样颗粒 |
| JP2008513035A (ja) * | 2004-09-21 | 2008-05-01 | サイトス バイオテクノロジー アーゲー | Ａｐ２０５のコートタンパク質と抗原性ポリペプチドとの融合タンパク質を含んでなるウイルス粒子 |
| WO2007011904A2 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technologies Inc. | Recombinant flu vaccines |
| CN101605558A (zh) * | 2005-08-16 | 2009-12-16 | 夏威夷生物技术公司 | 流感重组亚单位疫苗 |
| JP5714799B2 (ja) * | 2005-10-18 | 2015-05-07 | ノババックス インコーポレイテッド | 機能的インフルエンザウイルス様粒子（ｖｌｐ） |
| WO2007068747A1 (en) * | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| CU23576A1 (es) * | 2006-02-28 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Antígenos vacunales quiméricos contra el virus de la influenza aviar |
| CN101394864A (zh) * | 2006-03-07 | 2009-03-25 | 法克斯因内特公司 | 包含血细胞凝集素的组合物、制造其的方法与使用其的方法 |
| CA2638760A1 (en) * | 2006-03-07 | 2007-09-13 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
-
2010
- 2010-04-30 AU AU2010243490A patent/AU2010243490A1/en not_active Abandoned
- 2010-04-30 WO PCT/EP2010/055944 patent/WO2010125202A1/en not_active Ceased
- 2010-04-30 CN CN201080019069.9A patent/CN102573915B/zh not_active Expired - Fee Related
- 2010-04-30 CA CA2759873A patent/CA2759873A1/en not_active Abandoned
- 2010-04-30 EP EP10719754A patent/EP2424570A1/en not_active Withdrawn
- 2010-04-30 NZ NZ596058A patent/NZ596058A/xx not_active IP Right Cessation
- 2010-04-30 US US13/318,099 patent/US20120263743A1/en not_active Abandoned
- 2010-04-30 JP JP2012507784A patent/JP2012525134A/ja active Pending
- 2010-04-30 SG SG2011079225A patent/SG175382A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010125202A1 (en) | 2010-11-04 |
| US20120263743A1 (en) | 2012-10-18 |
| EP2424570A1 (en) | 2012-03-07 |
| AU2010243490A1 (en) | 2011-11-24 |
| CN102573915B (zh) | 2015-02-18 |
| SG175382A1 (en) | 2011-12-29 |
| CA2759873A1 (en) | 2010-11-04 |
| CN102573915A (zh) | 2012-07-11 |
| JP2012525134A (ja) | 2012-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007011904A3 (en) | Recombinant flu vaccines | |
| WO2009026397A3 (en) | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods | |
| WO2008014521A3 (en) | Improved vaccines and methods for using the same | |
| WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
| EP4241785A3 (en) | Influenza virus vaccines and uses thereof | |
| TW200732476A (en) | Functional influenza virus like particles (VLPs) | |
| MX392585B (es) | Particulas similares al virus de la influenza quimericas que comprenden hemaglutinina. | |
| EA033386B1 (ru) | Рекомбинантные иммуногенные полипептиды стеблевого домена гемагглютинина вируса гриппа а и их применение | |
| WO2007095320A3 (en) | Hpv antigens, vaccine compositions, and related methods | |
| AU2014310935B2 (en) | Combination vaccine | |
| GEP20135924B (en) | Chimeric viruses presenting non-native surface proteins and usage thereof | |
| EP3199545A3 (en) | Computationally optimized broadly reactive antigens for h1n1 influenza | |
| ATE552846T1 (de) | Verbesserter grippeimpfstoff | |
| MY166953A (en) | Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses | |
| EA201071086A1 (ru) | Усовершенствованный способ получения вакцинных антигенов вируса гриппа | |
| HK1203524A1 (en) | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses | |
| NZ741875A (en) | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof | |
| ZA202100386B (en) | Influenza virus hemagglutinin mutants | |
| MY163972A (en) | Attenuated recombinant newcastle disease virus and vaccine containing the same | |
| NZ596058A (en) | Influenza hemagglutinin compositions and uses thereof | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| WO2011039180A3 (en) | Novel vaccine composition against influenza | |
| EP3599247A3 (en) | Recombinant hemagglutinin protein of influenza virus and vaccine containing the same | |
| MX390927B (es) | Partículas semejantes a virus recombinantes que utilizan la proteína gag del virus de inmunodeficiencia bovina. | |
| EP4477231A3 (en) | Combination vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 APR 2017 BY DENNEMEYER SA Effective date: 20140314 |
|
| LAPS | Patent lapsed |